Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors
  2. Takebe, Naoko; Coyne, Geraldine O'Sullivan; Kummar, Shivaani; Collins, Jerry; Reid, Joel M; Piekarz, Richard; Moore, Nancy; Juwara, Lamin; Johnson,Barry; Bishop, Rachel; Lin, Frank I; Mena, Esther; Choyke, Peter L; Lindenberg, M Liza; Rubinstein, Larry V; Bonilla, Cecilia Monge; Goetz, Matthew P; Ames, Matthew M; McGovern, Renee M; Streicher, Howard; Covey, Joseph M; Doroshow, James H; Chen, Alice P
  3. Oncotarget. 2021, Feb 16; 12(4): 268-277.
  1. 2.   Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention
  2. Walter, Katherine R; Ford, Marvella E; Gregoski, Mathew J; Kramer, Rita M; Knight, Kendrea D; Spruill, Laura; Nogueira, Lourdes M; Krisanits, Bradley A; Phan, Van; La Rue, Amanda C; Lilly, Michael B; Ambs, Stefan; Chan,King; Turner, Tonya F; Varner, Heidi; Singh, Shweta; Uribarri, Jaime; Garrett-Mayer, Elizabeth; Armeson, Kent E; Hilton, Ebony J; Clair, Mark J; Taylor, Marian H; Abbott, Andrea M; Findlay, Victoria J; Peterson, Lindsay L; Magwood, Gayenell; Turner, David P
  3. Breast cancer research and treatment. 2019, Feb; 173(3): 559-571.
  1. 3.   Development of an image analysis screen for estrogen receptor alpha (ER alpha) ligands through measurement of nuclear translocation dynamics
  2. Dull, A.; Goncharova, E.; Hager, G.; McMahon, J. B.
  3. Journal of Steroid Biochemistry and Molecular Biology. 2010, Nov; 122(5): 341-351.
  1. 4.   Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment
  2. Waalkes, M. P.; Liu, J.; Ward, J. M.; Powell, D. A.; Diwan, B. A.
  3. Cancer Research. 2006, FEB 1; 66(3): 1337-1345.
  1. 5.   Cancer biology and hormesis: Comments on Calabrese (2005)
  2. Anderson, L. M.
  3. Critical Reviews in Toxicology. 2005, JUL; 35(6): 583-586.
  1. 6.   Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity
  2. Jansen, A. P.; Camalier, C. E.; Stark, C.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2004 3(2): 103-110.
  1. 7.   Single Amino Acid Substitutions At the N-Terminus of a Recombinant Cytotoxic Ribonuclease Markedly Influence Biochemical and Biological Properties
  2. Newton, D. L.; Boque, L.; Wlodawer, A.; Huang, C. Y.; Rybak, S. M.
  3. Biochemistry. 1998 37(15): 5173-5183.
  1. 8.   Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen
  2. Diwan, B. A.; Anderson, L. M.; Ward, J. M.
  3. Annual Meeting of the American Association for Cancer Research. 1997, 38 A3105.
  1. 9.   Synthesis and Biological Evaluation of 1,1-Dichloro-2,3-Diarylcyclopropanes As Antitubulin and Anti-Breast Cancer Agents
  2. Jonnalagadda, S. S.; Terhaar, E.; Hamel, E.; Lin, C. M.; Magarian, R. A.; Day, B. W.
  3. Bioorganic & Medicinal Chemistry. 1997 5(4): 715-722.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel